SR9011
id:
sr9011-184-5629518
title:
SR9011
text:
SR9011 is a research drug that was developed by Professor Thomas Burris of Scripps as an agonist of Rev-ErbAα
with a half-maximum inhibitory concentration (IC50) = 790 nM for Rev-Erbα and IC50 = 560 nM for Rev-ErbAβ. It has been used in the study of the regulation of the circadian rhythm and its links to immune system function, inflammation and cancer.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/SR9011
date created:
2013-08-23T01:02:32Z
date modified:
2024-09-07T17:47:10Z
main entity:
{"identifier":"Q15410183","url":"https://www.wikidata.org/entity/Q15410183"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/3/37/SR9011.svg","width":512,"height":267}
fields total:
13
integrity:
16